Medica RCP |Visipaque | Indications | Side Effects | Composition | Route | all.price

Do You Know

03-05-2023 : 769 Pharmacists work as Medical Representative, of which 39 work as Senior Medical Representative * 02-06-2020 : 216 non Pharmacists work as Medical Representative, and 54 work as Senior Medical Representative * 05-06-2023 : In Lebanon, 88 generic medicinal products are more expensive than their Originators * 31-12-2019 : A medicinal product refused in Europe is marketed in Lebanon * 05-06-2023 : At least 332 medicinal products are available on the Lebanese market and are not available in the country of origin * 05-06-2023 : The price of the most expensive medicine available in Lebanon is 30434557 LL * 05-06-2023 : At least 1309 medicinal products are more expensive in Lebanon than in the countries of origin * 01-01-2019 : Daktavira, a generic of Daklinza, is registered in Lebanon but has no public price * 31-12-2019 : 352 medicinal products have been declared as non-marketed or withdrawn * 09-11-2021 : 64.72% of lebanese pharmacists are female * 31-12-2019 : 486 medicines were submitted to the Ministry of Health for a marketing authorization, and 514 medicines were registered to date * 15-06-2018 : The Minister of Public Health, has decided to suspend the commercialization of AB Slim (Ab Care Medical Herbs), which contains sibutramine, sildenafil and phenolphthalein * 01-06-2020 : Some Non-Marketed medicines are still imported * 01-06-2020 : Ixempra, a medicinal product withdrawn in Europe is imported to lebanon * 01-06-2020 : A vaccine made in India, removed from WHO list of prequalified vaccines, is submitted for registration in Lebanon * 01-06-2020 : Lebanon has 14 CROs, and is ranked as one of the largest countries in the world in clinical studies. According to the WHO, 817 clinical studies are currently conducted in Lebanon. * 05-01-2021 : * 01-10-2023 : Adakveo is now withdrawn from use in the European Union due to lack of therapeutic efficacy *

Products » Items » Visipaque

Contraindicated

May be acceptable

Visipaque :
Type	Medicine-Like
Originator	B
Agent	Droguerie de l'Union
Distributor	Droguerie de l'Union
Laboratory	GE HealthCare
Manufacturer	GE HC
Origin	Ireland
ATC	V08AB09

Visipaque :

Injectable

Intraarterial

Intraarticular

Intrathecal

Intrauterin

Intravenous

Oral

Rectal

Visipaque :

V Various

V08 Contrast media

V08A X-ray contrast media, iodinated

V08AB Water-soluble, nephrotropic, low osmolar X-ray contrast media

V08AB09 iodixanol

Visipaque :

Iodixanol : 320mg/ml

Visipaque :

Adults : Aortography 40-60ml

Adults : Arthrography 1-15ml

Children : Cardioangiography 30-60ml

Adults : Cerebral angiography 5-10ml

Adults : Hysterosalpingography 40ml

Adults : Peripheral angiography 30-60ml

Adults : Urography 40-80ml

Children : Urography 2-4ml/kg

Adults : Venography 50-150ml/leg

Visipaque :

Calcium chloride

Hydrochloric acid (E507)

Sodium calcium edetate

Sodium chloride

Trometamol

Water for injections

* Excipient with known effect

Hazard Level
◼ Major
◼ Moderate
◼ Minor
◼ Safe

Visipaque :

Revision Date : 01/02/2017

Frequency	Percentage
Very Common	≥ 1/10
Common	≥ 1/100 - < 1/10
Uncommon	≥ 1/1,000 - < 1/100
Rare	≥ 1/10,000 - < 1/1,000
Very Rare	< 1/10,000
Unknown	Cannot be Estimated

Effect	Frequency
Abdominal discomfort	Very rare
Abdominal pain	Very rare
Acute generalised exanthematous pustulosis (AGEP)	Not known
Agitation	Very rare
Amnesia	Very rare
Anaphylactoid reactions	Not known
Anaphylactoid shock	Not known
Angina pectoris	Not known
Angioedema (Angioneurotic oedema) (Quincke oedema)	Very rare
Anxiety	Very rare
Arrhythmia	Rare
Arterial spasm	Not known
Arthralgia (Pain joint) (Joint ache)	Not known
Back pain	Very rare
Blindness cortical	Very rare
Bradycardia	Rare
Cardiac arrest	Not known
Cardiac failure	Not known
Cardio-respiratory arrest	Not known
Cerebrovascular accident	Very rare
Chest pain	Uncommon
Coma	Not known
Conduction disorders	Not known
Confusional state	Not known
Consciousness abnormal	Not known
Convulsion	Not known
Coronary artery thrombosis	Not known
Cough	Rare
Dermatitis bullous	Not known
Dizziness	Rare
Drug eruption	Not known
Dysguesia (taste perversion) (Taste abnormality) (Taste disturbance)	Very rare
Dyspnoea (dyspnea)	Very rare
Erythema	Very rare
Erythema multiforme	Not known
Fatigue	Very rare
Feeling cold	Very rare
Feeling hot	Uncommon
Flushing	Uncommon
Hallucination	Not known
Headache	Uncommon
Hypersensitivity	Uncommon
Hypertension	Very rare
Hypotension	Rare
Iodism	Not known
Ischaemia	Very rare
Lyell Syndrome (Toxic epidermal necrolysis)	Not known
Malaise	Very rare
Motor dysfunction	Not known
Muscle spasms	Very rare
Myocardial infarction	Not known
Nausea	Uncommon
Pancreatitis acute	Not known
Pancreatitis aggravated	Not known
Paraesthesia (paresthesia)	Very rare
Pruritus	Uncommon
Pulmonary oedema	Not known
Renal failure acute (Acute renal insufficiency) (Kidney failure acute) (Renal insufficiency acute)	Very rare
Respiratory arrest	Not known
Respiratory failure	Not known
Salivary gland enlargement	Not known
Shock	Not known
Skin rash	Uncommon
Stevens-Johnson syndrome	Not known
Syncope	Very rare
Tachycardia	Rare
Thrombocytopenia (Thrombopenia)	Not known
Thrombophlebitis	Not known
Thrombosis	Not known
Tremor	Not known
Urticaria	Uncommon
Ventricular hypokinesia	Not known
Visual impairment	Very rare
Vomiting	Uncommon

Visipaque :

Abu Dhabi

Belgium

Cyprus

Czech Republic

Denmark

Finland

France

Greece

Iceland

Italy

KSA

Kuweit

New Zealand

Norway

Oman

Spain

Switzerland

The Netherlands

Turkey

UAE

Coming Very Soon

Different Units By MoH Code

Revision Date : 01/02/2017

Visipaque MoH 2061762 :

Form Injectable/rectal Solution

Packaging Bottle (Glass)

Package Size 10x50ml

Strength 320mg/ml

Storage Condition <30°C protect from light

Stratum N/A

NSSF ✘

Quarantine ✘

Submission date 01/01/2008

Registration Year 2008

Price Comparison